Botulinum toxin type A prophylactic treatment for episodic migraine using a modified follow-the-pain treatment paradigm: A randomized, double-blind, placebo controlled, phase II study

被引：0
|
作者：
Aurora, SK
Gawel, M
Brandes, J
Pokta, S
VanDenburgh, AM
机构：
[1] Swedish Pain Ctr, Seattle, WA USA
[2] Sunnybrook Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
[3] Nashville Neurosci Grp PC, Nashville, TN USA
[4] Allergan Pharmaceut Inc, Irvine, CA USA
来源：
HEADACHE | 2005年 / 45卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：825 / 826
页数：2
相关论文
共 50 条
  • [21] Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study
    Noruzzadeh, Rezvan
    Modabbernia, Amirhossein
    Aghamollaii, Vajiheh
    Ghaffarpour, Majid
    Harirchian, Mohammad Hossein
    Salahi, Sarvenaz
    Nikbakht, Nikta
    Noruzi, Nahid
    Tafakhori, Abbas
    HEADACHE, 2016, 56 (01): : 95 - 103
  • [22] Botulinum neurotoxin type a for treatment of chronic migraine: double-blind, randomized, placebo-controlled PREEMPT trials
    Dodick, D. W.
    Aurora, S. K.
    Turkel, C. C.
    DeGryse, R. E.
    Silberstein, S. D.
    Lipton, R. B.
    Diener, H. -C.
    Brin, M. F.
    CEPHALALGIA, 2009, 29 (12) : 1350 - 1350
  • [23] A randomized, double-blind comparison of botulinum toxin type A (Botox®) and divalproex sodium (Depakote®) for the prophylactic treatment of migraine headaches:: a pilot study
    Porter, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S490 - S491
  • [24] Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
    Simpson, DM
    Alexander, DN
    OBrien, CF
    Tagliati, M
    Aswad, AS
    Leon, JM
    Gibson, J
    Mordaunt, JM
    Monaghan, EP
    NEUROLOGY, 1996, 46 (05) : 1306 - 1310
  • [25] Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: A randomized, controlled, double-blind multicenter study
    Ernberg, Malin
    Hedenberg-Magnusson, Britt
    List, Thomas
    Svensson, Peter
    PAIN, 2011, 152 (09) : 1988 - 1996
  • [26] Treatment of tension-type headache with botulinum toxin type A: A double-blind, placebo-controlled study
    Rollnik, JD
    Tanneberger, O
    Schubert, M
    Schneider, U
    Dengler, R
    HEADACHE, 2000, 40 (04): : 300 - 305
  • [27] Treatment of tension-type headache by injections of botulinum toxin type A: Double-blind placebo controlled study
    Relja, MA
    Korsic, M
    NEUROLOGY, 1999, 52 (06) : A203 - A203
  • [28] Levetiracetam for prophylactic treatment of pediatric migraine: A randomized double-blind placebo-controlled trial
    Montazerlotfelahi, Hadi
    Amanat, Man
    Tavasoli, Ali Reza
    Agah, Elmira
    Zamani, Gholam Reza
    Sander, Josemir W.
    Badv, Reza Shervin
    Mohammadi, Mahmoud
    Dehghani, Mahdieh
    Heidari, Morteza
    Hosseini, Seyed Ahmad
    Salehi, Mona
    Ashrafi, Mahmoud Reza
    CEPHALALGIA, 2019, 39 (12) : 1509 - 1517
  • [29] Botulinum toxin A (BoNT/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China
    Li, Yang
    Zhu, Ting
    Shen, Tingting
    Wu, Wenqi
    Cao, Jiaqian
    Sun, Jiawei
    Liu, Jing
    Zhou, Xuping
    Jiang, Caixia
    Tang, Zhen
    Liu, Tong
    Chen, Lihua
    Hu, Hua
    Luo, Weifeng
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 318 : 48 - 53
  • [30] Efficacy of Dysport® (Botulinum toxin type A) for the treatment of cervical dystonia:: A multicenter, randomized, double-blind, placebo-controlled phase III study
    Truong, Daniel
    Lew, Mark
    Orlova, Olga
    TOXICON, 2008, 51 : 37 - 38
12345